Business
Novavax chief ‘not able to predict’ Australian approval date for vaccine – Sydney Morning Herald
The company behind the third major COVID vaccine that Australia has ordered has been delayed in filing for global approvals.
The chief executive of coronavirus vaccine maker Novavax has admitted the company will have to delay filing for approvals of the product until July and will not put a date on when the vaccine is likely to receive the green light in Australia.
The Australian government has ordered 51 million doses of the Novavax vaccine, which had been expected to start being delivered as early as September this year.
Novavax said the trial, which enrolled 15,000 people aged 18 to 84, was expected to be used to apply…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Noosa News24 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
Business23 hours agoASX ETFs to target amidst an ageing population
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute